Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Eur J Pharm Biopharm. 2017 Jan 25;114:108–118. doi: 10.1016/j.ejpb.2017.01.011

Figure 8.

Figure 8

Testing the delivery efficiency of F31 nanoparticles into the Her-2 (+) SKBR-3 cells without aptamer (A.) or with aptamer labeling (B.). SKBR-3 cells were transfected with/without aptamer-labeled F31 nanoparticles for 24h and the delivery of siRNA into the cells was imaged using a fluorescence microscope at 10× magnification.